Acetazolamide attenuates hunter-cheyne-stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure

Annals of the American Thoracic Society

Volumn 11, Issue 1, 2014, Pages 80-86

  Javaheri, Shahrokh ^a   Sands, Scott A ^b   Edwards, Bradley A ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acetazolamide; Carbon dioxide; Cheyne Stokes respiration; Sleep apnea, central; Ventilation

Indexed keywords

ACETAZOLAMIDE; CARBON DIOXIDE; PLACEBO; POTASSIUM CHLORIDE;

AGED; APNEA HYPOPNEA INDEX; ARTERIAL BLOOD; ARTERIAL GAS; ARTICLE; CARBON DIOXIDE TENSION; CENTRAL SLEEP APNEA SYNDROME; CHEMOSENSITIVITY; CHEYNE STOKES BREATHING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART FUNCTION; HUMAN; HUNTER CHEYNE STOKES BREATHING; HYPERCAPNIC VENTILATORY RESPONSE; LUNG FUNCTION; MALE; POLYSOMNOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC HEART FAILURE;

ACETAZOLAMIDE; AGED; BLOOD GAS ANALYSIS; CARBON DIOXIDE; CARBONIC ANHYDRASE INHIBITORS; CHEMORECEPTOR CELLS; CHEYNE-STOKES RESPIRATION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HEART FAILURE; HUMANS; HYPERCAPNIA; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RESPIRATORY PHYSIOLOGICAL PHENOMENA; SLEEP APNEA, CENTRAL;

EID: 84893437599     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201306-201OC     Document Type: Article

References (39)

1. MacDonald M, Fang J, Pittman SD, White DP, Malhotra A. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med 2008;4:38-42. (Pubitemid 352038668)
2. Corrà U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, Bosimini E, Gnemmi M, Giannuzzi P. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 2006;113:44-50.
3. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, Giannuzzi P. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999;99: 1435-1440. (Pubitemid 29140908)
4. Jilek C, Krenn M, Sebah D, Obermeier R, Braune A, Kehl V, Schroll S, Montalvan S, Riegger GA, Pfeifer M, et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail 2011;13:68-75.
5. Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, et al.; CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007;115:3173-3180. (Pubitemid 47012231)
6. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000;101:392-397. (Pubitemid 30067395)
7. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006;173:234-237. (Pubitemid 43187897)
8. Fontana M, Emdin M, Giannoni A, Iudice G, Baruah R, Passino C. Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. Am J Cardiol 2011;107:1675-1680.
9. Solin P, Roebuck T, Johns DP, Walters EH, Naughton MT. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 2000; 162:2194-2200. (Pubitemid 32051686)
10. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 1999;341:949-954. (Pubitemid 29441549)
11. Francis DP, Willson K, Davies LC, Coats AJ, Piepoli M. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation 2000;102:2214-2221.
12. Cherniack NS, Longobardo GS. Cheyne-Stokes breathing: an instability in physiologic control. N Engl J Med 1973;288:952-957.
13. Khoo MCK, Kronauer RE, Strohl KP, Slutsky AS. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 1982; 53:644-659. (Pubitemid 12027236)
14. Nakayama H, Smith CA, Rodman JR, Skatrud JB, Dempsey JA. Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep. Am J Respir Crit Care Med 2002;165:1251-1260.
15. Tojima H, Kunitomo F, Kimura H, Tatsumi K, Kuriyama T, Honda Y. Effects of acetazolamide in patients with the sleep apnoea syndrome. Thorax 1988;43:113-119. (Pubitemid 18045557)
16. Wagenaar M, Teppema L, Berkenbosch A, Olievier C, Folgering H. Effect of low-dose acetazolamide on the ventilatory CO2 response during hypoxia in the anaesthetized cat. Eur Respir J 1998;12: 1271-1277. (Pubitemid 29011414)
17. Yamauchi M, Dostal J, Strohl KP. Acetazolamide protects against posthypoxic unstable breathing in the C57BL/6J mouse. J Appl Physiol (1985) 2007;103:1263-1268.
18. Teppema LJ, Dahan A, Olievier CN. Low-dose acetazolamide reduces CO(2)-O(2) stimulus interaction within the peripheral chemoreceptors in the anaesthetised cat. J Physiol 2001;537: 221-229. (Pubitemid 33076968)
19. Teppema LJ, Dahan A. Acetazolamide and breathing: does a clinical dose alter peripheral and central CO(2) sensitivity? Am J Respir Crit Care Med 1999;160:1592-1597.
20. White DP, Zwillich CW, Pickett CK, Douglas NJ, Findley LJ, Weil JV. Central sleep apnea: improvement with acetazolamide therapy. Arch Intern Med 1982;142:1816-1819. (Pubitemid 12036216)
21. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, Roselle GA. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998;97:2154-2159. (Pubitemid 28262123)
22. Javaheri S, Colangelo G, Lacey W, Gartside PS. Chronic hypercapnia in obstructive sleep apnea-hypopnea syndrome. Sleep 1994;17:416-423. (Pubitemid 24271515)
23. Javaheri S, Parker TJ, Wexler L, Michaels SE, Stanberry E, Nishyama H, Roselle GA. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995;122:487-492.
24. Bonnet M, Carley D, Carskadon M. Eeg arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15: 173-184.
25. Javaheri S, Guerra LF. Effects of domperidone and medroxyprogesterone acetate on ventilation in man. Respir Physiol 1990;81:359-370. (Pubitemid 20294279)
26. Read DJ. A clinical method for assessing the ventilatory response to carbon dioxide. Australas Ann Med 1967;16:20-32.
27. Sands SA, Edwards BA, Kee K, Turton A, Skuza EM, Roebuck T, O'Driscoll DM, Hamilton GS, Naughton MT, Berger PJ. Loop gain as a means to predict a positive airway pressure suppression of Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 2011;184:1067-1075.
28. Wilcox I, McNamara SG, Dodd MJ, Sullivan CE. Ventilatory control in patients with sleep apnoea and left ventricular dysfunction: comparison of obstructive and central sleep apnoea. Eur Respir J 1998;11:7-13. (Pubitemid 28081788)
29. Kiwull-Schöne HF, Teppema LJ, Kiwull PJ. Low-dose acetazolamide does affect respiratory muscle function in spontaneously breathing anesthetized rabbits. Am J Respir Crit Care Med 2001;163:478-483.
30. Wagenaar M, Teppema L, Berkenbosch A, Olievier C, Folgering H. The effect of low-dose acetazolamide on the ventilatory CO2 response curve in the anaesthetized cat. J Physiol 1996;495:227-237. (Pubitemid 26288467)
31. Coates EL, Li AH, Nattie EE. Acetazolamide on the ventral medulla of the cat increases phrenic output and delays the ventilatory response to CO2. J Physiol 1991;441:433-451.
32. Iturriaga R, Mokashi A, Lahiri S. Dynamics of carotid body responses in vitro in the presence of CO2-HCO3-: role of carbonic anhydrase. J Appl Physiol (1985) 1993;75:1587-1594.
33. Teppema LJ, Dahan A. Low-dose acetazolamide reduces the hypoxic ventilatory response in the anesthetized cat. Respir Physiol Neurobiol 2004;140:43-51. (Pubitemid 38510378)
34. Swenson ER. Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eut Respir J 1998;12:1242-1247. (Pubitemid 29011408)
35. Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD. Nocturnal rostral fl uid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121:1598-1605.
36. Szollosi I, Thompson BR, Krum H, Kaye DM, Naughton MT. Impaired pulmonary diffusing capacity and hypoxia in heart failure correlates with central sleep apnea severity. Chest 2008;134:67-72. (Pubitemid 352008765)
37. Solin P, Bergin P, Richardson M, Kaye DM, Walters EH, Naughton MT. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999;99:1574-1579. (Pubitemid 29152924)
38. Naughton MT. Cheyne-Stokes respiration: friend or foe? Thorax 2012; 67:357-360.
39. Edwards BA, Sands SA, Eckert DJ, White DP, Butler JP, Owens RL, Malhotra A, Wellman A. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea. J Physiol 2012;590:1199-1211.